Examines issues related to the pharmaceutical industry and the privatization of risk, discussing the role of the Food and Drug Administration in protecting the public, the effect of giving the private sector and markets greater responsibility and reducing public oversight, and other topics.
This book acquaints readers with controversies over popular prescription drugs and shows how Americans have attempted to balance the goals of access and safety.
